Nektar Therapeutics (NKTR)
57.74
-1.04
(-1.77%)
USD |
NASDAQ |
Dec 10, 16:00
57.20
-0.54
(-0.94%)
Pre-Market: 08:52
Nektar Therapeutics Free Cash Flow: -190.35M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Eli Lilly & Co. | 6.436B |
| Amicus Therapeutics, Inc. | 9.691M |
| Regeneron Pharmaceuticals, Inc. | 3.881B |
| Rigel Pharmaceuticals, Inc. | 68.14M |
| Zevra Therapeutics, Inc. | -24.23M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -48.76M |
| Cash from Investing (Quarterly) | -94.87M |
| Cash from Financing (Quarterly) | 141.68M |
| Free Cash Flow Per Share (Quarterly) | -2.580 |
| Free Cash Flow to Equity (Quarterly) | -39.22M |
| Free Cash Flow to Firm (Quarterly) | -42.83M |
| Free Cash Flow Yield | -5.11% |